Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells

Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potentia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroimmunology 2015-09, Vol.286, p.5-12
Hauptverfasser: Taka, Equar, Mazzio, Elizabeth A, Goodman, Carl B, Redmon, Natalie, Flores-Rozas, Hernan, Reams, Renee, Darling-Reed, Selina, Soliman, Karam F.A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue
container_start_page 5
container_title Journal of neuroimmunology
container_volume 286
creator Taka, Equar
Mazzio, Elizabeth A
Goodman, Carl B
Redmon, Natalie
Flores-Rozas, Hernan
Reams, Renee
Darling-Reed, Selina
Soliman, Karam F.A
description Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin > MIP-1alpha > MIP-1 g > IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells.
doi_str_mv 10.1016/j.jneuroim.2015.06.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1727674089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S016557281500168X</els_id><sourcerecordid>1706576002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</originalsourceid><addsrcrecordid>eNqNkUtv1TAQRi0EoreFv1BlySbB78cGUSqgSFdiwUPsLF9nAg6JXeyk0v33OLotCzawms2ZmW_OIHRJcEcwkS_Hboyw5hTmjmIiOiw7TMgjtCNa0VZzSh6jXQVFKxTVZ-i8lBFXkHHzFJ1RSY1mRO_Q_iouoQ1xmNw8uyXlYwPDAH4pTRqa5cdxTr_WEFOEJsTG-SXcuQX65s3XljZz8Dl9n4KbGg_TVJ6hJ4ObCjy_rxfoy7u3n69v2v3H9x-ur_atF5gvLReSC9-bQy1KGjVwIdwA5gBc04PrFZNM8N4wro2QTIExNbnpgVGnsAR2gV6c5t7mmg7KYudQtgQuQlqLJYoqqTjW5j9QLGsIjGlF5QmtR5WSYbC3OcwuHy3BdpNuR_sg3W7SLZa2Sq-Nl_c71sMM_Z-2B8sVeH0CoEq5C5Bt8QGihz7kqtr2Kfx7x6u_RvgpxODd9BOOUMa05liVW2ILtdh-2l6_fZ6I-nWpv7HfiMeqCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706576002</pqid></control><display><type>article</type><title>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Taka, Equar ; Mazzio, Elizabeth A ; Goodman, Carl B ; Redmon, Natalie ; Flores-Rozas, Hernan ; Reams, Renee ; Darling-Reed, Selina ; Soliman, Karam F.A</creator><creatorcontrib>Taka, Equar ; Mazzio, Elizabeth A ; Goodman, Carl B ; Redmon, Natalie ; Flores-Rozas, Hernan ; Reams, Renee ; Darling-Reed, Selina ; Soliman, Karam F.A</creatorcontrib><description>Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin &gt; MIP-1alpha &gt; MIP-1 g &gt; IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells.</description><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/j.jneuroim.2015.06.011</identifier><identifier>PMID: 26298318</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Allergy and Immunology ; Animals ; Anti-Inflammatory Agents - pharmacology ; Benzoquinones - pharmacology ; Black cumin seed ; Cell Line, Transformed ; Cell Survival - drug effects ; Cytokines ; Cytokines - genetics ; Cytokines - metabolism ; Dose-Response Relationship, Drug ; Enzyme Inhibitors - pharmacology ; Enzyme-Linked Immunosorbent Assay ; Gene Expression Regulation - drug effects ; Lipopolysaccharides - pharmacology ; Lysine - analogs &amp; derivatives ; Lysine - pharmacology ; Mice ; Microglia - drug effects ; Microglia - metabolism ; Microglial cells, Parkinson's, neurodegeneration ; Neurology ; Nigella sativa ; Nitric oxide ; Nitric Oxide Synthase Type II - metabolism ; Nitrites - metabolism ; RNA, Messenger - metabolism ; Thymoquinone</subject><ispartof>Journal of neuroimmunology, 2015-09, Vol.286, p.5-12</ispartof><rights>Elsevier B.V.</rights><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</citedby><cites>FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jneuroim.2015.06.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26298318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taka, Equar</creatorcontrib><creatorcontrib>Mazzio, Elizabeth A</creatorcontrib><creatorcontrib>Goodman, Carl B</creatorcontrib><creatorcontrib>Redmon, Natalie</creatorcontrib><creatorcontrib>Flores-Rozas, Hernan</creatorcontrib><creatorcontrib>Reams, Renee</creatorcontrib><creatorcontrib>Darling-Reed, Selina</creatorcontrib><creatorcontrib>Soliman, Karam F.A</creatorcontrib><title>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</title><title>Journal of neuroimmunology</title><addtitle>J Neuroimmunol</addtitle><description>Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin &gt; MIP-1alpha &gt; MIP-1 g &gt; IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells.</description><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Benzoquinones - pharmacology</subject><subject>Black cumin seed</subject><subject>Cell Line, Transformed</subject><subject>Cell Survival - drug effects</subject><subject>Cytokines</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Lysine - analogs &amp; derivatives</subject><subject>Lysine - pharmacology</subject><subject>Mice</subject><subject>Microglia - drug effects</subject><subject>Microglia - metabolism</subject><subject>Microglial cells, Parkinson's, neurodegeneration</subject><subject>Neurology</subject><subject>Nigella sativa</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Nitrites - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Thymoquinone</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1TAQRi0EoreFv1BlySbB78cGUSqgSFdiwUPsLF9nAg6JXeyk0v33OLotCzawms2ZmW_OIHRJcEcwkS_Hboyw5hTmjmIiOiw7TMgjtCNa0VZzSh6jXQVFKxTVZ-i8lBFXkHHzFJ1RSY1mRO_Q_iouoQ1xmNw8uyXlYwPDAH4pTRqa5cdxTr_WEFOEJsTG-SXcuQX65s3XljZz8Dl9n4KbGg_TVJ6hJ4ObCjy_rxfoy7u3n69v2v3H9x-ur_atF5gvLReSC9-bQy1KGjVwIdwA5gBc04PrFZNM8N4wro2QTIExNbnpgVGnsAR2gV6c5t7mmg7KYudQtgQuQlqLJYoqqTjW5j9QLGsIjGlF5QmtR5WSYbC3OcwuHy3BdpNuR_sg3W7SLZa2Sq-Nl_c71sMM_Z-2B8sVeH0CoEq5C5Bt8QGihz7kqtr2Kfx7x6u_RvgpxODd9BOOUMa05liVW2ILtdh-2l6_fZ6I-nWpv7HfiMeqCQ</recordid><startdate>20150915</startdate><enddate>20150915</enddate><creator>Taka, Equar</creator><creator>Mazzio, Elizabeth A</creator><creator>Goodman, Carl B</creator><creator>Redmon, Natalie</creator><creator>Flores-Rozas, Hernan</creator><creator>Reams, Renee</creator><creator>Darling-Reed, Selina</creator><creator>Soliman, Karam F.A</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope></search><sort><creationdate>20150915</creationdate><title>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</title><author>Taka, Equar ; Mazzio, Elizabeth A ; Goodman, Carl B ; Redmon, Natalie ; Flores-Rozas, Hernan ; Reams, Renee ; Darling-Reed, Selina ; Soliman, Karam F.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-45645cd9b6457697f455afe9be482bad736354d934895637e990159de32a706e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Benzoquinones - pharmacology</topic><topic>Black cumin seed</topic><topic>Cell Line, Transformed</topic><topic>Cell Survival - drug effects</topic><topic>Cytokines</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Lysine - analogs &amp; derivatives</topic><topic>Lysine - pharmacology</topic><topic>Mice</topic><topic>Microglia - drug effects</topic><topic>Microglia - metabolism</topic><topic>Microglial cells, Parkinson's, neurodegeneration</topic><topic>Neurology</topic><topic>Nigella sativa</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Nitrites - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Thymoquinone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taka, Equar</creatorcontrib><creatorcontrib>Mazzio, Elizabeth A</creatorcontrib><creatorcontrib>Goodman, Carl B</creatorcontrib><creatorcontrib>Redmon, Natalie</creatorcontrib><creatorcontrib>Flores-Rozas, Hernan</creatorcontrib><creatorcontrib>Reams, Renee</creatorcontrib><creatorcontrib>Darling-Reed, Selina</creatorcontrib><creatorcontrib>Soliman, Karam F.A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taka, Equar</au><au>Mazzio, Elizabeth A</au><au>Goodman, Carl B</au><au>Redmon, Natalie</au><au>Flores-Rozas, Hernan</au><au>Reams, Renee</au><au>Darling-Reed, Selina</au><au>Soliman, Karam F.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells</atitle><jtitle>Journal of neuroimmunology</jtitle><addtitle>J Neuroimmunol</addtitle><date>2015-09-15</date><risdate>2015</risdate><volume>286</volume><spage>5</spage><epage>12</epage><pages>5-12</pages><issn>0165-5728</issn><eissn>1872-8421</eissn><abstract>Abstract Thymoquinone (TQ), the main pharmacological active ingredient within the black cumin seed ( Nigella sativa ) is believed to be responsible for the therapeutic effects on chronic inflammatory conditions such as arthritis, asthma and neurodegeneration. In this study, we evaluated the potential anti-inflammatory role of TQ in lipopolysaccharide (LPS)-stimulated BV-2 murine microglia cells. The results obtained indicate that TQ was effective in reducing NO 2− with an IC50 of 5.04 μM, relative to selective iNOS inhibitor LNIL- l -N6-(1-iminoethyl)lysine (IC50 4.09 μM). TQ mediated reduction in NO 2− was found to parallel the decline of iNOS protein expression as confirmed by immunocytochemistry. In addition, we evaluated the anti-inflammatory effects of TQ on ninety-six (96) cytokines using a RayBio AAM-CYT-3 and 4 cytokine antibody protein array. Data obtained establish a baseline protein expression profile characteristic of resting BV-2 cells in the order of osteopontin &gt; MIP-1alpha &gt; MIP-1 g &gt; IGF-1 and MCP-I. In the presence of LPS [1 ug/ml], activated BV-2 cells produced a sharp rise in specific pro-inflammatory cytokines/chemokine's IL-6, IL-12p40/70, CCL12 /MCP-5, CCL2/MCP-1, and G-CSF which were attenuated by the addition of TQ (10 μM). The TQ mediated attenuation of MCP-5, MCP-1 and IL-6 protein in supernatants from activated BV-2 cells were corroborated by independent ELISA. Moreover, the data obtained from the RT2 PCR demonstrated a similar pattern where the LPS mediated elevation of mRNA for IL-6, CCL12/MCP-5, CCL2/MCP-1 were significantly attenuated by TQ (10 μM). Also, in this study, consistent data were obtained for both protein antibody array densitometry and ELISA assays. In addition, TQ was found to reduce LPS mediated elevation in gene expression of Cxcl10 and a number of other cytokines in the panel. These findings demonstrate the significant anti-inflammatory properties of TQ in LPS activated microglial cells. Therefore, the obtained results might indicate the usefulness of TQ in delaying the onset of inflammation-mediated neurodegenerative disorders involving activated microglia cells.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26298318</pmid><doi>10.1016/j.jneuroim.2015.06.011</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0165-5728
ispartof Journal of neuroimmunology, 2015-09, Vol.286, p.5-12
issn 0165-5728
1872-8421
language eng
recordid cdi_proquest_miscellaneous_1727674089
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Allergy and Immunology
Animals
Anti-Inflammatory Agents - pharmacology
Benzoquinones - pharmacology
Black cumin seed
Cell Line, Transformed
Cell Survival - drug effects
Cytokines
Cytokines - genetics
Cytokines - metabolism
Dose-Response Relationship, Drug
Enzyme Inhibitors - pharmacology
Enzyme-Linked Immunosorbent Assay
Gene Expression Regulation - drug effects
Lipopolysaccharides - pharmacology
Lysine - analogs & derivatives
Lysine - pharmacology
Mice
Microglia - drug effects
Microglia - metabolism
Microglial cells, Parkinson's, neurodegeneration
Neurology
Nigella sativa
Nitric oxide
Nitric Oxide Synthase Type II - metabolism
Nitrites - metabolism
RNA, Messenger - metabolism
Thymoquinone
title Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A45%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-inflammatory%20effects%20of%20thymoquinone%20in%20activated%20BV-2%20microglial%20cells&rft.jtitle=Journal%20of%20neuroimmunology&rft.au=Taka,%20Equar&rft.date=2015-09-15&rft.volume=286&rft.spage=5&rft.epage=12&rft.pages=5-12&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/j.jneuroim.2015.06.011&rft_dat=%3Cproquest_cross%3E1706576002%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706576002&rft_id=info:pmid/26298318&rft_els_id=1_s2_0_S016557281500168X&rfr_iscdi=true